In AD, the amyloid deposits consist predominantly of a peptide of 39–43 amino acids called amyloid-β peptide (Aβ) [13], [14], resulting from the pathogenic processing of the amyloid β precursor protein (APP) by sequential cleavage by β-secretase and γ-secretase [15], [16]. This evidence concerns the gene APP and Alzheimer disease.